MUC16 and ovarian carcinoma: Even though signaling pathways via the MUC16 cytoplasmic domain are largely unknown, a strong correlation between the serum CA125/MUC16 level and ovarian cancer prognosis also suggests that MUC16 is a potential therapeutic target for the treatment of ovarian cancer [20].